Ingalls & Snyder LLC’s GE HealthCare GEHC Stock Holding History

Ingalls & Snyder LLC’s Portfolio GEHC Stock Details GEHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-2,633	Closed	-$247K	–	459
2024 Q3	$247K	Buy	+2,633	New	+$221K	0.01%	388

Other funds holding GEHC

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Ingalls & Snyder LLC's GEHC Position: Q4 2024 in Review

Ingalls & Snyder LLC sold out of GE HealthCare (GEHC) in Q4 2024, closing a stake of 2,633 shares — an estimated $247K sold.

Ingalls & Snyder LLC first reported a position in GEHC in Q3 2024 and held it in 1 quarter. The position peaked at $247K in Q3 2024. 1,329 funds tracked by Wall St. Rank hold GEHC as of Q4 2024.

Ingalls & Snyder LLC reported no remaining GE HealthCare position as of Q4 2024 after selling out during the quarter.
Ingalls & Snyder LLC sold 2,633 GE HealthCare shares in Q4 2024, an estimated $247K.
Ingalls & Snyder LLC first reported a position in GE HealthCare in Q3 2024 and held it in 1 quarter.
Ingalls & Snyder LLC's GE HealthCare position peaked at $247K in Q3 2024.
1,329 funds tracked by Wall St. Rank held GE HealthCare as of Q4 2024.

Based on Ingalls & Snyder LLC's 13F filing for Q4 2024, filed 29 Jan 2025.